Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

133
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
133
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

11
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
11
Antibiotic Selection00:57

Antibiotic Selection

55.0K
Overview
55.0K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

30
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
30
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.5K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.5K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

22
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models.

The Journal of infectious diseases·2026
Same author

Evaluating Dalbavancin Suppression Therapy in Patients at High Risk for Recurrent Infections.

The Annals of pharmacotherapy·2026
Same author

Core Content Related to Teaching Biomechanical Aspects of Human Movement for Physical Therapist Students: A Modified Delphi Study.

Journal, physical therapy education·2026
Same author

Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

Antimicrobial agents and chemotherapy·2026
Same author

Longitudinal analysis of viral and host RNA in blood and saliva during controlled human dengue virus 3 infections.

Journal of virology·2026
Same author

Dengue antibody dynamics resolved at epitope level using a dengue 1 human infection model.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Related Experiment Video

Updated: Aug 22, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K

Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.

Wesley D Kufel1,2,3, Katie A Parsels2,3, Bruce E Blaine4

  • 1Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.

Pharmacotherapy
|November 13, 2022
PubMed
Summary
This summary is machine-generated.

Vancomycin plus ceftaroline effectively cleared persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) in complex patients. This combination therapy showed good tolerability, offering a promising salvage regimen for difficult-to-treat MRSAB infections.

Keywords:
MRSAbacteremiaceftarolinecombination therapydaptomycinpersistentsalvagevancomycin

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.1K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.1K

Related Experiment Videos

Last Updated: Aug 22, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.1K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.1K

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacology
  • Antimicrobial Stewardship

Background:

  • Persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) poses a significant clinical challenge.
  • Optimal antibiotic salvage regimens for MRSAB remain incompletely defined.
  • Evaluating novel therapeutic combinations is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess the effectiveness and safety of vancomycin combined with ceftaroline as a salvage regimen for persistent MRSAB.
  • To determine the time to bacterial clearance and other clinical outcomes in patients receiving this combination therapy.

Main Methods:

  • A retrospective cohort study was conducted at a tertiary care academic medical center.
  • Adult patients with persistent MRSAB receiving vancomycin plus ceftaroline were evaluated.
  • Key outcomes included time to MRSAB clearance, microbiological cure, and safety parameters.

Main Results:

  • The median time to MRSAB clearance after initiating ceftaroline was 2.6 days.
  • Microbiological cure was achieved in 96.7% of patients.
  • Adverse effects were generally mild, with rash being the most common (6.7%).

Conclusions:

  • Vancomycin plus ceftaroline appears to be an effective and well-tolerated salvage regimen for persistent MRSAB.
  • This combination offers a viable treatment option for patients with complex and refractory infections.
  • Further prospective studies are warranted to confirm these findings.